We have located links that may give you full text access.
CASE REPORTS
JOURNAL ARTICLE
Angiosarcoma of the liver: MR imaging pre- and post-chemotherapy.
Angiosarcoma of the liver is a rare tumor of mesenchymal origin. We report the MR appearance of angiosarcoma of the liver on T1-weighted, T2-weighted, and serial gadolinium enhanced spoiled gradient echo images pre- and post-intravenous chemotherapy. On pre-treatment images, angiosarcoma lesions were well defined, high signal with central regions of low signal on T2-weighted images, and showed peripheral nodular enhancement on serial post gadolinium images. Lesions resembled hemangiomas, however low signal central regions on T2-weighted images was a distinguishing feature. Post-treatment images acquired 11, 15, and 17 months after initiation of therapy, demonstrated decrease in diameter or resolution of angiosarcoma masses. Lesions increased in signal on T1 weighted images and decreased in signal on T2 weighted images approaching the signal intensity of liver. Treated liver lesions enhanced negligibly on gadolinium enhanced images.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
Perioperative echocardiographic strain analysis: what anesthesiologists should know.Canadian Journal of Anaesthesia 2024 April 11
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app